Senate Files

Bills

S. 1095 119th Congress

Stop STALLING Act

Latest action, Apr 10, 2025: Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

6 cosponsors

Sponsored by Amy Klobuchar (Democrat). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
4 D · 2 R
  • Democrat
  • Republican
  • Independent
6 senators cosponsoring

Referred to: Senate: Judiciary Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

20 clientsQ1 2025Q3 2026

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
7 reports
BCBSM INC
7 reports
BLUE CROSS AND BLUE SHIELD ASSOCIATION
7 reports
BLUE CROSS AND BLUE SHIELD OF FLORIDA INC
7 reports
GSK (FKA GLAXOSMITHKLINE INC.)
7 reports
GUIDEWELL MUTUAL HOLDING CORPORATION
7 reports
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
7 reports
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
CROSSROADS STRATEGIES, LLC
7 reports
TEVA PHARMACEUTICALS USA, INC.
FAEGRE DRINKER BIDDLE & REATH LLP
7 reports
THE CAMPAIGN FOR SUSTAINABLE RX PRICING
MEHLMAN CONSULTING, INC.
7 reports
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
WHITMER & WORRALL, LLC
6 reports
NOVARTIS
6 reports
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
6 reports
BIOTECHNOLOGY INNOVATION ORGANIZATION
5 reports
BLUE CROSS AND BLUE SHIELD OF KANSAS INC
5 reports
The top 25 of 28 clients, by reports
ClientLobbying firmReportsReports totalingFromToSenate
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)7$28.6MQ1 2025Q3 2026yes
BCBSM INC7$206KQ1 2025Q3 2026yes
BLUE CROSS AND BLUE SHIELD ASSOCIATION7$8.8MQ1 2025Q3 2026yes
BLUE CROSS AND BLUE SHIELD OF FLORIDA INC7$810KQ1 2025Q3 2026yes
GSK (FKA GLAXOSMITHKLINE INC.)7$8.9MQ1 2025Q3 2026yes
GUIDEWELL MUTUAL HOLDING CORPORATION7$40KQ1 2025Q3 2026yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA7$64.5MQ1 2025Q3 2026yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICACROSSROADS STRATEGIES, LLC7$0Q1 2025Q3 2026yes
TEVA PHARMACEUTICALS USA, INC.FAEGRE DRINKER BIDDLE & REATH LLP7$0Q1 2025Q3 2026yes
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.7$630KQ1 2025Q3 2026yes
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC6$300KQ1 2025Q2 2026yes
NOVARTIS6$13.1MQ1 2025Q2 2026yes
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION6$20.0MQ1 2025Q3 2026yes
BIOTECHNOLOGY INNOVATION ORGANIZATION5$8.9MQ1 2025Q3 2026yes
BLUE CROSS AND BLUE SHIELD OF KANSAS INC5$50KQ4 2025Q3 2026yes
COUNCIL FOR INNOVATION PROMOTION (C4IP)5$450KQ4 2025Q3 2026yes
T1INTERNATIONAL USA4$0Q1 2025Q1 2026yes
AARP3$15.6MQ1 2025Q1 2026yes
BLUECROSS BLUESHIELD OF TENNESSEE3$780KQ1 2026Q3 2026yes
KAISER FOUNDATION HEALTH PLAN INC3$1.6MQ4 2025Q3 2025yes
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INCCOVINGTON & BURLING LLP3$0Q1 2025Q2 2026yes
PUBLIC CITIZEN3$306KQ4 2025Q3 2026yes
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)2$710KQ2 2026Q3 2026yes
BLUE CROSS BLUE SHIELD OF MICHIGAN2$542KQ1 2025Q3 2026yes
AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES1$700KQ4 2025Q4 2025yes